APA (7th ed.) Citation

PA, L., D, R., S, G., H, K., W, S., I, B., . . . WR, G. (2014). Efficacy and safety of rifampicin for multiple system atrophy: A randomised, double-blind, placebo-controlled trial. The Lancet. Neurology, 13(3), 268. https://doi.org/10.1016/S1474-4422(13)70301-6

Chicago Style (17th ed.) Citation

PA, Low, et al. "Efficacy and Safety of Rifampicin for Multiple System Atrophy: A Randomised, Double-blind, Placebo-controlled Trial." The Lancet. Neurology 13, no. 3 (2014): 268. https://doi.org/10.1016/S1474-4422(13)70301-6.

MLA (9th ed.) Citation

PA, Low, et al. "Efficacy and Safety of Rifampicin for Multiple System Atrophy: A Randomised, Double-blind, Placebo-controlled Trial." The Lancet. Neurology, vol. 13, no. 3, 2014, p. 268, https://doi.org/10.1016/S1474-4422(13)70301-6.